+ Watch YONG
on My Watchlist
The company develops, manufactures, and distributes fulvic-acid-based nutrient compounds for plant and animal feed in China.
I'm done with discussing this stock. I've called it a dog since the 7s, its in the 3s now, and if you don't think it is going to 0, nothing I say will change your mind.
Pre-market: 5.64 +1.89 (50.40%) May 31, 8:54AM EDT From Google FinanceBig Gain from CEO's Plans to Purchase of up to $3.0 Million. I'd hate to be a short right now.....Could go back down depending on how this is executed, but it looks like its going up from here.The only reason the stock price took a tumble was from the short selling and accusations.Not going to comment who is right or wrong about the accusations, but if the market is going to look past that, the stock should jump again from here.
Hahahahah - you get what you deserve!!! Making fraudulent claims to benefit you and your friends always comes back to bite you. You obviously have no ethics and are now being punished.
These buyouts never actually occur. Just look at the HRBN nonsense.
Nice pop today.
It's not a buyout, Ian. Morgan Stanley is taking a $50 million stake in preferred shares.
Morgan Stanley is buying preferred shares much like Warren Buffet did when Goldman Sachs was significantly undervalued. Additionally, Morgan Stanley now has someone on YONG's Board which should reassure everyone that there is not fraud involved in this company. They simply have a solid product that Chinese farmers can't get enough of. Ian please refute anything I said here, in all honesty, why are you shorting stocks when you are a gold mining expert with a degree from the prestigious Colorado State.
Not sure why everyone is talking smack to a guy who not only has a current CAPS rating of 99.24, but was actually right all along. If I were you guys, I would dust off the lens through which you see things, and re-examine your beloved falling stock. Good luck to all.
Nightshaded: I hope you're not equating CAPS rating with the ability to correctly choose stocks and make money. He pads his CAPS rating by locking in many small gains, thereby increasing the accuracy component of his rating. His score, which represents the value of his picks against the market, fluctuates wildly and at present is barely holding above zero.That said, this has nothing to do with CAPS or talking smack. This is about a hit piece he wrote containing wild inaccuracies about YONG which were swiftly pointed out by its management and stockholders. Despite the quality of responses, his article promptly dropped the stock price and started a chain of follow-up articles and supposed research reports continuing to bash the stock. Regardless of where this stock is and where it goes, mouthpieces like him should not be able to slander a stock, put shareholders in the house of pain, and force management to waste time addressing it. Period.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions